Taro Pharmaceuticals U.S.A., Inc. recalls Clotrimazole and Betamethasone Dipropionate Cream USP, 1%/0.05%,15 g tubes, Rx only, Manufactured by: Taro Pharmaceuticals…
Failed Content Uniformity Specifications: Out-of-specification result for the Betamethasone Dipropionate assay of a stability sample
Read the official notice →- Date
- 2022-04-06
- Country
- United States
- Brand
- Taro Pharmaceuticals U.S.A
- Product
- Clotrimazole and Betamethasone Dipropionate Cream USP, 1%/0.05%,15 g tubes, Rx only, Manufactured by: Taro Pharmaceuticals Industries Ltd.…
- Classification
- Class III
- Units
- Product was distributed to one retail consignee in NY.
- Category
- Drugs & medical
- Source
- FDA · Drug
Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer
What to do
- Check the product name, strength and lot number against the official notice.
- Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
- Ask the pharmacy or supplier about a replacement or refund.
General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.
More Taro Pharmaceuticals U.S.A recalls
- 2024-08-21
US
Taro Pharmaceuticals U.S.A., Inc. recalls Hydrocortisone 1% & Acetic Acid 2% Otic Solution, 10 mL bottle, Rx only, Mfg by: Taro Pharmaceuticals, Inc., Brampton,…
Failed Impurities/Degradation Specifications: Out-of-specification results obtained for related impurities and slightly lower than the established level of the Hydrocortisone Assay obtained during stability testing.
FDA · DrugTaro Pharmaceuticals U.S.A., Inc.Product was distributed to one distributorOfficial notice →- 2022-01-19
US
Taro Pharmaceuticals U.S.A., Inc. recalls Clobetasol Propionate Ointment USP, 0.05%, 60g tubes, Rx only, Mfd. by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel…
Microbial Contamination of Non-Sterile Products: presence of R. Pickettii bacteria
FDA · DrugTaro Pharmaceuticals U.S.A., Inc.Two distributors in UT and LA who could have further distributed to the retail…Official notice →
Other drugs & medical recalls in the United States
- 2022-04-06
US
Dr. Reddy's Laboratories, Inc. recalls Lansoprazole Delayed-Release Capsules, USP, 30 mg, 90-count bottle, Rx Only, Manufactured By: Dr. Reddy's Laboratories Limited,…
Failed Dissolution Specifications; during long term stability testing.
US
Aurolife Pharma, LLC recalls Glycopyrrolate Tablets, USP, 1 mg, 100-count bottle, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road,…
Presence of Foreign Substance: Complaint for pieces of glass discovered in a sealed bottle which came from equipment within the packaging room.
US
Drug Depot, Inc., dba APS Pharmacy recalls TESTOSTERONE CYPIONATE/ ANASTROZOLE *GS* OIL (10ML) 200MG/0.5MG/ML; Packaged in a multi dose 10ML vial, as a) (CA) 4 ML…
Lack of sterility assurance.
FDA · DrugDrug Depot, Inc., dba APS PharmacyNationwide in the USA including Puerto Rico.Official notice →US
Dr. Reddy's Laboratories, Inc. recalls Atorvstatin Calcium Tablets, USP 80 mg*, 90 Tablets, Rx Only, Mrd. By: Dr. Reddy's Laboratories Limited, Srikakulam - 532 409,…
Failed Impurities/Degradation Specifications: Out of Specification results for related substance.
- 2022-03-31
US
Maped Helix USA Recalls Metal Lockable Drug Chests Due to Risk of Poisoning
The locking mechanism can fail allowing access to the contents inside the chest, posing a risk of poisoning.
- 2022-03-30
US
Dignitana, Inc. recalls DigniCap Delta Scalp Cooling System, Product Number: 900-1001, Labeling: The DigniCap Scalp Cooling System User Manual (PN:…
Instructions for Use (IFUs) updated to include use of a headband is now recommended for all patients and instructions for the application of the headband. Additionally, IFU updated to include warnings for risk of…
FDA · DeviceDignitana, Inc.US Distribution to states of: LA, NC, NJ, FL, WI, CA, NY, KS, GA, SC, CT and KY.Official notice →